Aurora Daljit Singh
See Remarks
Aurora Daljit Singh has filed 4 SEC Form 4 filings (29 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Aug 21, 2026.
On the most recent filing, Aurora Daljit Singh is listed as See Remarks at Neumora Therapeutics, Inc. Inside the rolling window, Aurora Daljit Singh reported no open-market purchases and 7 open-market sales totaling $1.0M in NMRA. The largest disclosed transaction in the window is a sale of 114,703 NMRA shares on Nov 11, 2025, worth $307K.
Companies traded
Other insiders at NMRA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Aurora Daljit Singh made?
Aurora Daljit Singh has filed 4 SEC Form 4 filings (29 transaction rows) across 1 company since 2025.
Which companies does Aurora Daljit Singh trade?
Aurora Daljit Singh has filed SEC Form 4 disclosures for 1 company, including NMRA.
When was Aurora Daljit Singh's most recent SEC Form 4 filing?
Aurora Daljit Singh's most recent SEC Form 4 filing on Tracefour is dated Aug 21, 2026.
What is Aurora Daljit Singh's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Aurora Daljit Singh is listed as See Remarks.
What is Aurora Daljit Singh's total buy and sell value in the current window?
Inside the rolling retention window, Aurora Daljit Singh bought $0 and sold $1.0M based on SEC Form 4 filings.
What was Aurora Daljit Singh's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 114,703 NMRA shares on 2025-11-11, worth $307K, per SEC Form 4 filings.